Trial Profile
Pharmacokinetics of Valganciclovir in Kidney and Kidney/Pancreas Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary) ; Ganciclovir
- Indications Cytomegalovirus infections
- Focus Pharmacokinetics
- 18 May 2010 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.
- 12 May 2010 New trial record